CClinicalTrials.gg
Status unknownNCT03937115COMPETEUpdated May 3, 2019

Effect of tDCS on Sport Performance for Two Categories of Athletes : Explosive Profile and Enduring Profile

An interventional study of Active tDCS and Sham tDCS in Healthy Volunteers and High-level Sportsman, sponsored by Centre Hospitalier Universitaire de Besancon. Status unknown at 2 sites in France. Open to male participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-03.

Sponsored by Centre Hospitalier Universitaire de Besancon · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified May 2019), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Nov 2018, registered Mar 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
Male
01

Study summary

The study aims to compare the effects of tDCS applied on the dorsolateral prefrontal cortex (dlPFC) vs sham on the neuromuscular system. Two types of athletes will benefit from stimulation: jumper and cyclists. Short and long term effects are assesed by electromyographic records, experimental tasks and self-rated scales.

Read the detailed description

Transcranial direct current stimulation is a technique of noninvasive brain stimulation which delivers a electrical current to the scalp to modulate the neuronal activity. Depending on the polarity of stimulation, tDCS induces a neural hyperexcitability (with anode) or hypoexcitability (with cathode) of the target area.

Due to its neuromodulatory action, ease of use and low safety, tDCS can be used as a potential treatment but also as an investigative tool in neurophysiology. Thus, studies have shown a beneficial effect of tDCS on cognitive and motor functions. Nevertheless, studies conducted on motor performance and the reduction of neuromuscular fatigue show disparate results. It is impossible to conclude whether tDCS allows for improved performance and is a means of doping.

With a prospective, sham-controlled, crossover, double-blind design, this study aims to evaluate the effect of tDCS on neuromuscular fatigue resistance during explosive (jumping) and endurance (cycling) exertion.

This study is divided into two parts:

  • Part A: jumping group
  • Part B: cycling group.

During Part A, participants visit the laboratory on 3 occasions. Each visit is organized in the same way and is at least 48 hours apart from the previous one.

Participants are divided into two groups according to their level of experience (amateurs vs. high level).

Before the session of tDCS, participants carry out a psychometric assessment (MCQ, BIS10) and experimental tasks (BART, EEFRT, STROOP test and Go NoGo task). Then, they performed three types of jumps (long jump, squat jump and countermovement jump). Finally, participants benefit from neuromuscular tests (EMG recording of plantar flexor muscle activity, percutaneous stimulation of the posterior tibial nerve).

Subjects will be submitted to three sessions of tDCS (2 actives and one sham), one by visit, in the order of randomization. Current intensity will be of 2 mA (or 0 mA), through 25 cm² surface electrodes, during 20 minutes. The positioning of the stimulation electrodes will be carried out in compliance with EEG 10/20 standards:

  • Sequence order determined by randomization:
  1. Anode: F3 / Cathode: AF8/ Stimulation intensity: 2 mA
  2. Anode: F3/ Cathode: AF8/ Stimulation intensity: 0 mA
  3. Anode: FC2/ Cathode: Left shoulder/ Stimulation intensity: 2 mA

Immediately after the stimulation, participants perform motor and cognitive task again and the results are compared.

During part B, subjects participate in two training sessions of five days each. The training sessions are one month apart.

Participants are divided into three groups according to their level of experience (amateurs vs. high level vs. sedentary).

Each day, the subjects perform two twenty-minute time trials during which they receive a session of tDCS. (one week with the active tDCS, one week with the sham). So, subjects will be submitted to 10 tDCS stimulation sessions (active or sham) for five consecutive days (2 sessions of 20 minutes/day). Current intensity will be of 2 mA, through 25 cm² surface electrodes, placed over the dlPFC and the supraorbital region (anode position over F3 and cathode over AF8, according to the EEG 10-20 international system).

At J1 and J5 of each session (before and after session training), subjects carry out a psychometric assessment (MCQ, BIS10) and experimental tasks (BART, EEFRT, STROOP test and Go NoGo task) and benefit from neuromusculars tests (EMG recording of plantar flexor muscle activity, percutaneous stimulation of the posterior tibial nerve). Baseline measures will be compared to those obtained immediately after the end of sessions (5 days: short-term effects), and to 12 and 30 days later (long-term effects). Active and sham stimulation sessions outcomes will as well be compared.

02

Conditions studied

  • Healthy Volunteers
  • High-level Sportsman

Keywords

  • tDCS
  • Noninvasive brain stimulation
  • Endurance performance
  • Cognitive performance
03

In context

Lead sponsor

Centre Hospitalier Universitaire de Besancon is the lead sponsor of 439 studies on the registry; 97 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Man older than 18 years old
  • Right-handed
  • Signed informed Consent form
  • Subject affiliated to or beneficing from a French social security regime
  • According to groups :

    • Part A :

      • Group S1 : High level jump practice : more 4000 hours of practice during the last five years
      • Group S2 : Amateur jump practice : less 4000 hours of practice during the last five years
    • Part B :

      • Group C1 : High level cycling practice: more 4000 hours of practice during the last five years
      • Group C2 : Amateur cycling practice: less 4000 hours of practice during the last five years
      • Group T : Sedentary : less two hours of recreationally practice of sport by week

Exclusion criteria

Exclusion Criteria:

  • Younger than18 years old
  • Left-handed
  • Subject under measure of protection or guardianship of justice
  • Subject beneficiary from a legal protection regime
  • Subject unlikely to cooperate or low cooperation stated by investigator
  • Subject not covered by social security
  • Suject with comorbidities : addictive (except : tea, coffee, tobacco), psychiatric, severe somatic pathologies (specially tumors, degenerative disease) or progressive neurologic pathologie
  • Subject being in the exclusion period of another study or provided for by the "National Volunteer File"
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Group S1

    High level jump practice : more 4000 hours of practice during the last five years

    Device: Active tDCS · Device: Sham tDCS

  • Experimental
    Group S2

    Amateur jump practice : less 4000 hours of practice during the last five years

    Device: Active tDCS · Device: Sham tDCS

  • Experimental
    Group C1

    High level cycling practice: more 4000 hours of practice during the last five years

    Device: Active tDCS · Device: Sham tDCS

  • Experimental
    Group C2

    Amateur cycling practice: less 4000 hours of practice during the last five years

    Device: Active tDCS · Device: Sham tDCS

  • Experimental
    Group T

    Sedentary : less two hours of recreationally practice of sport by week

    Device: Active tDCS · Device: Sham tDCS

Interventions

  • DeviceActive tDCS

    2 active tDCS sessions (20 min each, 2 mA) applied to the dlPFC and right motor cortex

    Also known as: Starstim® (Neuroelectrics, Spain)

  • DeviceSham tDCS

    1 sham tDCS session (20 min, 0 mA) applied to the dlPFC

    Also known as: Starstim® (Neuroelectrics, Spain)

  • DeviceActive tDCS

    10 tDCS sessions (2 sessions/day for 5 days, 20 mA, 20 min each) applied to the dlPFC

    Also known as: Starstim® (Neuroelectrics, Spain)

  • DeviceSham tDCS

    10 tDCS sessions (2 sessions/day for 5 days, 0 mA, 20 min each) applied to the dlPFC

    Also known as: Starstim® (Neuroelectrics, Spain)

06

What researchers measure

Primary outcomes

  1. Performance (in meters) measured during jumps

    Performance measurement (in meters) during the three types of jumps (long jump, squat jump and countermovement jump) before and after tDCS session

    Time frame: Day 5

Secondary outcomes

  1. Average power during the time trial before and after 10 tDCS sessions

    Average power (in watts) measured during a 20min time trial before and after 10 tDCS sessions for 5 days

    Time frame: Day 35

  2. BIS-10 scores

    Compared scores from the French version of the Barratt Impulsiveness Scale (BIS-10). The French version of the BIS-10 is a self-rated 34 item questionnaire, composed by three subscales: motor-impulsivity, cognitive-impulsivity and non-planning-impulsivity. Each item is scored on a 0 to 4 points scale. Higher scores indicate higher levels of impulsivity.

    Time frame: Day 60

  3. MCQ scores

    Compared scores from the French version of the Monetary Choice Questionnaire. The MCQ is a self-rated 27 item questionnaire which assessed the discounting. Delay discounting is the decline in the present value of a reward with delay to its receipt. Example item: " Would you prefer 25€ today or 75€ in 15 days? " For each item, subjects must choose between a low immediate reward and a higher delayed reward. Waiting times vary from 7 days to 186 days, and rewards are divides into 3 magnitudes: low (25-35€), medium (50-60€), high (75-85€). This will allow assessing: * the influence of the the magnitude of the difference between the two rewards proposed, * the impact of the time on the reward's subjective value (speed at which the reward is devalued over time), reflected in the k index. This index is calculated separately for each magnitude, and an average index is calculated for each subject. The more the k index is high, the more the subject is considered impulsive.

    Time frame: Day 60

  4. Stroop task

    Compared results from the experimental Stroop task, assessing response inhibition.

    Time frame: Day 60

  5. Go/No-Go task

    Compared results from the experimental Go/No-Go task, assessing response inhibition.

    Time frame: Day 60

  6. Effort Expenditure for Reward Task

    Compared results from the experimental Effort Expenditure for Reward Task, assessing motivation

    Time frame: Day 60

  7. Balloon Analog Risk Task

    Compared results from the experimental Balloon Analog Risk task, assessing impulsivity

    Time frame: Day 60

  8. QIDS-C16 scale

    Compared scores from the French version of the Quick Inventory of Depressive Symptomatology. The QIDS-C16 is a 16 item questionnaire completed by the clinician to assess the depressive symptomatology and the severity of the depression. These 16 items are constructed around the 9 following symptoms: * sad mood, * concentration, * autocriticism, * suicidal thoughts, * ahnedonia, * fatigue, * sleep disorders, * appetite/weight changes, * psychomotor retardation/agitation. This scaled is based on the intensity of each symptom in the 7 last days, regardless of its chronicity or its recent apparition. Each symptom is rated 0 to 3. The total score thus vary from 0 to 27.

    Time frame: Day 60

  9. QIDS-SR16 scale

    Compared scores from the French version of the Quick Inventory of Depressive Symptomatology. The QIDS-SR16 is a self-rated 16 item questionnaire, assessing the intensity of depressive symptomatology. These 16 items are constructed around the 9 following symptoms: * sad mood, * concentration, * autocriticism, * suicidal thoughts, * ahnedonia, * fatigue, * sleep disorders, * appetite/weight changes, * psychomotor retardation/agitation. This scaled is based on the intensity of each symptom in the 7 last days, regardless of its chronicity or its recent apparition. Each symptom is rated 0 to 3. The total score thus vary from 0 to 27.

    Time frame: Day 60

07

Study locations

2 of 2 sites recruiting
  • CHU Besancon - Clinical Psychiatric Department
    Besancon, 25000, France
    Recruiting
  • EA4660- C3S, Culture, Sport, Santé, Société
    Besançon, 25000, France
    Recruiting
08

References and documents

Publications

  • Grandperrin Y, Grospretre S, Nicolier M, Gimenez P, Vidal C, Haffen E, Bennabi D. Effect of transcranial direct current stimulation on sports performance for two profiles of athletes (power and endurance) (COMPETE): a protocol for a randomised, crossover, double blind, controlled exploratory trial. Trials. 2020 Jun 3;21(1):461. doi: 10.1186/s13063-020-04412-0. PubMed 32493462 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03937115
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Responsible party
Sponsor
First posted
May 3, 2019
Start date
Nov 21, 2018
Primary completion
Apr 2020 (estimated)
Completion
Apr 2020 (estimated)
Last update
May 3, 2019

Study contacts

Magali NICOLIER PALLANDRE, PhD
Contact
mnicolier@chu-besancon.fr
00333 81 21 90 07
Djamila BENNABI, MD
principal investigator · CHU de Besançon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion